A popular statin should not be used because there is growing evidence of side effects, a doctor and campaigner has claimed.

AT least five medications now sold to consumers pose such risks that their sale should be limited or stopped, said a government drug reviewer who raised questions earlier about the arthritis drug Vioxx.

EUROPE'S three biggest drug companies will showcase new products at three keenly-awaited research and development presentations in the coming weeks, but none has a quick fix for sceptical investors, analysts say.